Label-Free Array Systems Market Size
| Study Period | 2019 - 2029 |
| Base Year For Estimation | 2023 |
| Forecast Data Period | 2024 - 2029 |
| CAGR | 6.20 % |
| Fastest Growing Market | Asia Pacific |
| Largest Market | North America |
Major Players
*Disclaimer: Major Players sorted in no particular order |
Label-Free Array Systems Market Analysis
The global label-free array systems market is anticipated to witness steady growth of approximately 6.2% CAGR during the forecast period. In recent years, label-free array systems have taken center stage as the research tool in many drug discovery processes. Label-free technologies are also used by manufacturers in context to patient samples, to produce biorelevant data that can result in effective drug development and precision medicine.
Modern medicine is moving toward precision or personalized medicine, to eliminate dosing redundancy in individuals. However, the biggest challenges in drug discovery and development are individual variability in drug effectiveness and a lack of translatability of pre-clinical results. Hence, companies are focusing on developing appropriate cellular models and readout systems to understand mechanisms and functional characterization on molecular and cellular levels. Moreover, next-gen label-free technologies, including mass spectrometers, biochips/microarrays, and others, have shown positive results in identifying clinical microorganisms. Companies are also developing micro plate-based optical biosensors that can be incorporated in the standard format microplates, to detect small molecules, cells, and proteins.
Label-Free Array Systems Market Trends
This section covers the major market trends shaping the Label-Free Array Systems Market according to our research experts:
The Surface Plasmon Resonance Technology Segment is Expected to the Exhibit the Fastest Growth During the Forecast Period
Based on the technology, the segmentation includes cellular dielectric spectroscopy, bio-layer interferometry, surface plasmon resonance, and other technologies. Among these, surface plasmon resonance technology is likely to experience a significant growth in the global label-free array systems market. The main contributors can be increasing spending over R&D activities by pharmaceutical and biopharmaceutical companies. According to the report of European Federation of Pharmaceutical Companies, in 2017, the R&D expenditure for European pharmaceutical industry was accounted to be around USD 38,404. Hence, it is expected to influence the market positively.
North America Accounted for the Largest Share in the Global Market and is also the Fastest-growing Market
Region-wise, North America is expected to emerge as the leading region in the global label-free array systems market. The rise in chronic and life-threatening diseases is resulting in an increase in drug discovery programs in the United States. This is leading to the increasing demand for label-free array systems in the region. The companies are also introducing label-free cell-based systems for early drug discovery. Meanwhile, certain issues, including a limit of detection and probability of the device, and the sensitivity of the device, are being optimized by manufacturers to offer better label-free array systems.
Label-Free Array Systems Industry Overview
The global label-free array systems market is dominated by a few major players, and the global label-free array systems market is expected to experience growth, owing to the rising collaboration and partnerships between pharmaceutical and biotechnology companies, for expediting various drug discovery/designing processes.
Label-Free Array Systems Market Leaders
-
Corning Incorporated
-
Danaher Corporation
-
ThermoFisher Scientific
-
GE Healthcare
-
Perkin Elmer Inc.
*Disclaimer: Major Players sorted in no particular order
Label-Free Array Systems Market Report - Table of Contents
1. INTRODUCTION
- 1.1 Study Deliverables
- 1.2 Study Assumptions
- 1.3 Scope of the Study
2. RESEARCH METHODOLOGY
3. EXECUTIVE SUMMARY
4. MARKET DYNAMICS
- 4.1 Market Overview
-
4.2 Market Drivers
- 4.2.1 Advantages over Labeled Detection Techniques
- 4.2.2 Increase in the R&D Expenditure of Pharmaceutical and Biotechnology Companies
- 4.2.3 Technological Advancements in Label-free Technologies
-
4.3 Market Restraints
- 4.3.1 High Instrumentation Costs
- 4.3.2 Lack of Awareness
-
4.4 Porter's Five Forces Analysis
- 4.4.1 Threat of New Entrants
- 4.4.2 Bargaining Power of Buyers/Consumers
- 4.4.3 Bargaining Power of Suppliers
- 4.4.4 Threat of Substitute Products
- 4.4.5 Intensity of Competitive Rivalry
5. MARKET SEGMENTATION
-
5.1 Technology
- 5.1.1 Surface Plasmon Resonance
- 5.1.2 Bio Layer Interferometry
- 5.1.3 Cellular Dielectric Spectroscopy
- 5.1.4 Other Technologies
-
5.2 Application
- 5.2.1 Drug Discovery
- 5.2.2 Protein Interface Analysis
- 5.2.3 Antibody Characterization and Development
- 5.2.4 Protein Complex and Cascade Analysis
- 5.2.5 Other Applications
-
5.3 End User
- 5.3.1 Contract Research Organizations
- 5.3.2 Agricultural Research Institutes
- 5.3.3 R&D Laboratories
- 5.3.4 Other End Users
-
5.4 Geography
- 5.4.1 North America
- 5.4.1.1 United States
- 5.4.1.2 Canada
- 5.4.1.3 Mexico
- 5.4.2 Europe
- 5.4.2.1 Germany
- 5.4.2.2 United Kingdom
- 5.4.2.3 France
- 5.4.2.4 Italy
- 5.4.2.5 Spain
- 5.4.2.6 Rest of Europe
- 5.4.3 Asia-Pacific
- 5.4.3.1 China
- 5.4.3.2 Japan
- 5.4.3.3 India
- 5.4.3.4 Australia
- 5.4.3.5 South Korea
- 5.4.3.6 Rest of Asia-Pacific
- 5.4.4 Middle East & Africa
- 5.4.4.1 GCC
- 5.4.4.2 South Africa
- 5.4.4.3 Rest of Middle East & Africa
- 5.4.5 South America
- 5.4.5.1 Brazil
- 5.4.5.2 Argentina
- 5.4.5.3 Rest of South America
6. COMPETITIVE LANDSCAPE
-
6.1 Company Profiles
- 6.1.1 Corning Incorporated
- 6.1.2 GE Healthcare
- 6.1.3 Bruker Corporation
- 6.1.4 Bio-rad Laboratories
- 6.1.5 Eppendorf AG
- 6.1.6 Fluiditic Analytics
- 6.1.7 ThermoFisher Scientific
- 6.1.8 Shimadzu Corporation
- 6.1.9 Danaher Corporation (Molecular Devices LLC - FORTEBIO)
- 6.1.10 PerkinElmer
- *List Not Exhaustive
7. MARKET OPPORTUNITIES AND FUTURE TRENDS
** Subject To AvailablityLabel-Free Array Systems Industry Segmentation
Biotechnology and pharmaceutical companies use label-free array systems in the drug discovery process. It works on the principle of refractive index, impedance-based assays, and optical interferometry, for identifying and validating new molecules as the possible drug candidates. The systems reduce the cost and time for drug identification and validation process. As per the scope of this report, the global label-free array systems market is segmented by technology, application, end user, and geography.
| Technology | Surface Plasmon Resonance | |
| Bio Layer Interferometry | ||
| Cellular Dielectric Spectroscopy | ||
| Other Technologies | ||
| Application | Drug Discovery | |
| Protein Interface Analysis | ||
| Antibody Characterization and Development | ||
| Protein Complex and Cascade Analysis | ||
| Other Applications | ||
| End User | Contract Research Organizations | |
| Agricultural Research Institutes | ||
| R&D Laboratories | ||
| Other End Users | ||
| Geography | North America | United States |
| Canada | ||
| Mexico | ||
| Geography | Europe | Germany |
| United Kingdom | ||
| France | ||
| Italy | ||
| Spain | ||
| Rest of Europe | ||
| Geography | Asia-Pacific | China |
| Japan | ||
| India | ||
| Australia | ||
| South Korea | ||
| Rest of Asia-Pacific | ||
| Geography | Middle East & Africa | GCC |
| South Africa | ||
| Rest of Middle East & Africa | ||
| Geography | South America | Brazil |
| Argentina | ||
| Rest of South America |
Label-Free Array Systems Market Research FAQs
What is the current Label-free Array Systems Market size?
The Label-free Array Systems Market is projected to register a CAGR of 6.20% during the forecast period (2024-2029)
Who are the key players in Label-free Array Systems Market?
Corning Incorporated, Danaher Corporation, ThermoFisher Scientific, GE Healthcare and Perkin Elmer Inc. are the major companies operating in the Label-free Array Systems Market.
Which is the fastest growing region in Label-free Array Systems Market?
Asia Pacific is estimated to grow at the highest CAGR over the forecast period (2024-2029).
Which region has the biggest share in Label-free Array Systems Market?
In 2024, the North America accounts for the largest market share in Label-free Array Systems Market.
What years does this Label-free Array Systems Market cover?
The report covers the Label-free Array Systems Market historical market size for years: 2019, 2020, 2021, 2022 and 2023. The report also forecasts the Label-free Array Systems Market size for years: 2024, 2025, 2026, 2027, 2028 and 2029.
Label-free Array Systems Industry Report
Statistics for the 2024 Label-free Array Systems market share, size and revenue growth rate, created by Mordor Intelligence™ Industry Reports. Label-free Array Systems analysis includes a market forecast outlook to 2029 and historical overview. Get a sample of this industry analysis as a free report PDF download.
